CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

CVRx, Inc.NASDAQ: CVRX

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin widens to -88.8%

Net margin was -88.8% in Q1 FY2026, up 22.6 pp from a year earlier. On a trailing-twelve-month basis it was -89.1%, up 8.3 pp year over year. Over 3 fiscal years it widened by 90.3 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 5 analysts of -90.8% for the fiscal year ending Dec 2026, up from -94.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-88.8%-14.4 pp QoQ
Last fiscal yearDec 2025
-94.1%+22.8 pp YoY
LTMMar 2026
-89.1%+8.3 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+22.6 pp+19.0 pp-3.7 pp
1 year+22.8 pp+3.3 pp-19.5 pp
3 years+90.3 pp+30.4 pp-59.9 pp
5 years+70.1 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-94.1%
Year-over-year change
+22.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How CVRX compares with its peers on the latest reported figures

  • CVRX's LTM Mar 2026 net margin of -89.1% is the 7th highest of the 10 companies compared; the peer median is -62.1%.
  • Its year-over-year change of +8.3 pp is the 4th highest of 10, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +90.3 pp compares with a peer median of +18.8 pp.
CVRX Competitors Peer median
Net Margin for CVRX and competitors
Company Period LTM level YoY 3-year change
SNWVSANUWAVE Health, Inc.LTM Mar 202636.2% +126.1 pp+88.3 pp
VMDViemed Healthcare, Inc.LTM Mar 20265.2% -0.1 pp+1.0 pp
CERSCerus CorporationLTM Mar 2026-4.3% +5.9 pp+18.8 pp
SGHTSight Sciences, Inc.LTM Mar 2026-46.8% +16.4 pp+71.2 pp
MASS908 Devices Inc.LTM Mar 2026-62.1% -30.8 pp+6.4 pp
QTRXQuanterix CorporationLTM Mar 2026-71.9% -36.2 pp+17.1 pp
CVRXCVRx, Inc.LTM Mar 2026-89.1% +8.3 pp+90.3 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
PRQRProQR Therapeutics N.V.LTM Mar 2026-339.4% -180.3 pp+1527.3 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-576.1% -101.8 pp+650.8 pp
Peer median (excluding CVRX) -62.1%-0.1 pp+18.8 pp

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.04M22.47M39.3M51.29M56.65M
Cost of Revenue3.64M5M6.26M8.33M8.31M
Gross Profit9.4M17.47M33.04M42.96M48.34M
Gross Margin72.1%77.8%84.1%83.8%85.3%
Research & Development7.5M9.95M11.63M11.13M11.13M
Selling, General & Admin27.86M50.05M64.51M91.32M88.47M
Operating Expenses35.36M60M76.14M102.45M99.61M
Depreciation & Amortization168K412K522K619K756K
EBITDA(40.6M)(40.74M)(38.73M)(54.89M)(46.74M)
EBITDA Margin-311.4%-181.3%-98.6%-107.0%-82.5%
Operating Income(25.97M)(42.53M)(43.1M)(59.49M)(51.27M)
Operating Margin-199.2%-189.3%-109.7%-116.0%-90.5%
Interest Income00000
Interest Expense2.22M165K1.8M4.4M5.83M
Other Income / Expenses(17.02M)1.21M2.05M(420K)(2.06M)
Income Before Tax(42.99M)(41.32M)(41.05M)(59.91M)(53.32M)
Pre-Tax Margin-329.8%-183.9%-104.5%-116.8%-94.1%
Income Tax Expense91K109K147K55K(18K)
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Net Margin-330.5%-184.4%-104.8%-116.9%-94.1%
EPS (Basic)(2.11)(2.02)(1.99)(2.65)(2.04)
EPS (Diluted)(2.11)(2.02)(1.99)(2.65)(2.04)
Weighted Avg Shares20.72M20.51M20.7M22.6M26.08M
Weighted Avg Shares (Diluted)20.72M20.53M20.75M22.6M26.08M

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.